Hellman S - Search Results

1

Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy.

Mauceri HJ, Beckett MA, Liang H, Sutton HG, Pitroda S, Galka E, Efimova E, Darga T, Khodarev NN, King CR, Posner MC, Hellman S, Kufe DW, Weichselbaum RR. Mauceri HJ, et al. Among authors: hellman s. Cancer Gene Ther. 2009 Apr;16(4):373-81. doi: 10.1038/cgt.2008.86. Epub 2008 Oct 31. Cancer Gene Ther. 2009. PMID: 18974777 Free PMC article.

2

Chemoinducible gene therapy: a strategy to enhance doxorubicin antitumor activity.

Lopez CA, Kimchi ET, Mauceri HJ, Park JO, Mehta N, Murphy KT, Beckett MA, Hellman S, Posner MC, Kufe DW, Weichselbaum RR. Lopez CA, et al. Among authors: hellman s. Mol Cancer Ther. 2004 Sep;3(9):1167-75. Mol Cancer Ther. 2004. PMID: 15367711

3

Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy.

Weichselbaum RR, Kufe DW, Hellman S, Rasmussen HS, King CR, Fischer PH, Mauceri HJ. Weichselbaum RR, et al. Among authors: hellman s. Lancet Oncol. 2002 Nov;3(11):665-71. doi: 10.1016/s1470-2045(02)00900-2. Lancet Oncol. 2002. PMID: 12424068 Review.

4

Genetic radiotherapy overcomes tumor resistance to cytotoxic agents.

Seung LP, Mauceri HJ, Beckett MA, Hallahan DE, Hellman S, Weichselbaum RR. Seung LP, et al. Among authors: hellman s. Cancer Res. 1995 Dec 1;55(23):5561-5. Cancer Res. 1995. PMID: 7585635

5

Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature.

Mauceri HJ, Hanna NN, Wayne JD, Hallahan DE, Hellman S, Weichselbaum RR. Mauceri HJ, et al. Among authors: hellman s. Cancer Res. 1996 Oct 1;56(19):4311-4. Cancer Res. 1996. PMID: 8813113

6

Spatial and temporal control of gene therapy using ionizing radiation.

Hallahan DE, Mauceri HJ, Seung LP, Dunphy EJ, Wayne JD, Hanna NN, Toledano A, Hellman S, Kufe DW, Weichselbaum RR. Hallahan DE, et al. Among authors: hellman s. Nat Med. 1995 Aug;1(8):786-91. doi: 10.1038/nm0895-786. Nat Med. 1995. PMID: 7585181

7

Importance of local control in an era of systemic therapy.

Hellman S, Weichselbaum RR. Hellman S, et al. Nat Clin Pract Oncol. 2005 Feb;2(2):60-1. doi: 10.1038/ncponc0075. Nat Clin Pract Oncol. 2005. PMID: 16264859 No abstract available.

8

Oligometastases revisited.

Weichselbaum RR, Hellman S. Weichselbaum RR, et al. Among authors: hellman s. Nat Rev Clin Oncol. 2011 Jun;8(6):378-82. doi: 10.1038/nrclinonc.2011.44. Epub 2011 Mar 22. Nat Rev Clin Oncol. 2011. PMID: 21423255 Review.

9

Transcriptional control of viral gene therapy by cisplatin.

Park JO, Lopez CA, Gupta VK, Brown CK, Mauceri HJ, Darga TE, Manan A, Hellman S, Posner MC, Kufe DW, Weichselbaum RR. Park JO, et al. Among authors: hellman s. J Clin Invest. 2002 Aug;110(3):403-10. doi: 10.1172/JCI15548. J Clin Invest. 2002. PMID: 12163460 Free PMC article.

10

Radiation oncology.

Hellman S, Weichselbaum RR. Hellman S, et al. JAMA. 1996 Jun 19;275(23):1852-3. JAMA. 1996. PMID: 8642748 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

607 results

Search Page

Filters